88
Participants
Start Date
October 27, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
JAB-21822
800mg, orally QD with 21 days each cycle, treatment till disease progression or intolerable toxicity or withdraw for other reasons
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Peking Union Medical College Hospital, Beijing
RECRUITING
Anhui Provincial Cancer Hospital, Hefei
RECRUITING
Beijing Tsinghua Changgung Hospital, Beijing
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
RECRUITING
The First Affiliated Hospital of Sun, Yat-sen University, Guangzhou
RECRUITING
Guangxi Medical University Cancer Hospital, Nanning
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
Hunan Provincial People's Hospital, Changsha
RECRUITING
Jiangsu Cancer Hospital, Nanjing
RECRUITING
Jiangsu Province Hospital, Nanjing
RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
Shandong Cancer Hospital, Jinan
NOT_YET_RECRUITING
The Affiliated Hospital of Qingdao University, Qingdao
RECRUITING
Huashan Hospital, Fudan University, Shanghai
RECRUITING
Shanghai Changhai Hospital, Shanghai
RECRUITING
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
RECRUITING
West China Hospital of Sichuan University, Chengdu
RECRUITING
Tianjin Medical University Cancer Institute＆Hospital, Tianjin
NOT_YET_RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
Lead Sponsor
Allist Pharmaceuticals, Inc.
INDUSTRY